Intrinsic Value of S&P & Nasdaq Contact Us

U.S. Physical Therapy, Inc. USPH NYSE

NYSE • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score
59/100
2/7 Pass
SharesGrow Intrinsic Value
$50.65
-34.3%
Analyst Price Target
$102.00
+32.2%

U.S. Physical Therapy, Inc. (USPH) — Analyst outlook / Analyst consensus target is. Based on 12 analyst ratings, the consensus is bullish — 9 Buy, 3 Hold.

The consensus price target is $102.00, representing an upside of 32.2% from the current price $77.13.

Analysts estimate Earnings Per Share (EPS) of $2.64 and revenue of $0.67B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $1.67 vs est $2.64 (missed -36.8%). 2025: actual $1.42 vs est $2.62 (missed -45.8%). Analyst accuracy: 29%.

USPH Stock — 12-Month Price Forecast

$102.00
▲ +32.24% Upside
Average Price Target
Based on 12 Wall Street analysts offering 12-month price targets for U.S. Physical Therapy, Inc., the price target is $102.00.
The average price target represents a +32.24% change from the last price of $77.13.

USPH Analyst Ratings

Buy
12
Ratings
9 Buy
3 Hold
Based on 12 analysts giving stock ratings to U.S. Physical Therapy, Inc. in the past 3 months
Rating breakdown
Buy
9 75%
Hold
3 25%
75%
Buy
9 analysts
25%
Hold
3 analysts
0%
Sell
0 analysts

EPS Estimates — USPH

29%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual $1.67 vs Est $2.64 ▼ 58.3% off
2025 Actual $1.42 vs Est $2.62 ▼ 84.6% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is declining. Analysts forecast meaningful EPS growth ahead.

Revenue Estimates — USPH

90%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.561B vs Est $0.666B ▼ 18.8% off
2025 Actual $0.781B vs Est $0.779B ▲ 0.3% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message